Sanofi boosts Sanofi Ventures with additional $625 million September 24, 2025
Sanofi Ventures drives innovation through leading and participating in private financing rounds for pioneering healthcare companies
Sanofi Ventures drives innovation through leading and participating in private financing rounds for pioneering healthcare companies
Amgen has invested over $40 billion in manufacturing and research and development in US since 2017
Harmonisation of listing structure requires a direct listing of AstraZeneca shares on the NYSE in place of existing US ADRs
82,514 sq ft facility to host up to 15 biotech companies, fueling the development of next-generation medicines
The new site enables end-to-end production of viral vector gene therapies
Represents one of the largest cell culture biomanufacturing sites in North America, which will employ 1,400 people by 2031
BIL also holds an option to increase its equity stake by an additional 15%
Subscribe To Our Newsletter & Stay Updated